Asthma Exacerbations and Triggers in Children in TENOR: Impact on Quality of Life  Bradley E. Chipps, MD, Tmirah Haselkorn, PhD, Karin Rosén, MD, PhD,

Slides:



Advertisements
Similar presentations
The Relationship Between a Specific IgE Level and Asthma Outcomes: Results from the National Health and Nutrition Examination Survey  Whitney.
Advertisements

Von Ta, MD, Andrew A. White, MD 
Advances in Diagnosing Peanut Allergy
Emergency Department Management of Hereditary Angioedema Attacks: Patient Perspectives  Iris M. Otani, MD, Sandra C. Christiansen, MD, Paula Busse, MD,
The XTEND-CIU study: Long-term use of omalizumab in chronic idiopathic urticaria  Marcus Maurer, MD, Allen Kaplan, MD, Karin Rosén, MD, PhD, Michael Holden,
Similar Efficacy with Omalizumab in Chronic Idiopathic/Spontaneous Urticaria Despite Different Background Therapy  Thomas B. Casale, MD, Jonathan A. Bernstein,
Vitamin D Insufficiency and Asthma in a US Nationwide Study
Allergy to Surgical Implants
Recombinant Human C1-Esterase Inhibitor to Treat Acute Hereditary Angioedema Attacks in Adolescents  James W. Baker, MD, Avner Reshef, MD, Dumitru Moldovan,
Chronic rhinosinusitis: Potential new use for topical sulfasalazine
Complementary and Alternative Medicine in Allergy-Immunology: More Information is Needed  Leonard Bielory, MD  The Journal of Allergy and Clinical Immunology:
Dennis K. Ledford, MD, Sally Wenzel, MD 
Desensitization to Chemotherapeutic Agents
Intramuscular Versus Intravenous Immunoglobulin Replacement Therapy and Measurement of Immunoglobulin Levels During Immunoglobulin Replacement Therapy 
Clinical Management of Food Allergy
An Infant with Atopic Dermatitis and Itching After Ingestion of Milk
Adult Asthma Scores—Development and Validation of Multivariable Scores to Identify Asthma in Surveys  Ana Sá-Sousa, MSc, Ana Margarida Pereira, MD, Rute.
Comparative Effectiveness of Budesonide-Formoterol Combination and Fluticasone- Salmeterol Combination for Asthma Management: A United States Retrospective.
Impact of Asthma Exacerbations and Asthma Triggers on Asthma-related Quality of Life in Patients with Severe or Difficult-to-Treat Asthma  Allan T. Luskin,
A randomized multicenter study evaluating Xolair persistence of response after long- term therapy  Dennis Ledford, MD, William Busse, MD, Benjamin Trzaskoma,
Test for Respiratory and Asthma Control in Kids (TRACK): A caregiver-completed questionnaire for preschool-aged children  Kevin R. Murphy, MD, Robert.
Melkersson-Rosenthal Syndrome
Validation of the Pregnancy Asthma Control Test
Demographic and clinical characteristics of children and adolescents with severe or difficult-to-treat asthma  Bradley E. Chipps, MD, Stanley J. Szefler,
Evaluation of Food Allergy in Patients with Atopic Dermatitis
The Relationship Between a Specific IgE Level and Asthma Outcomes: Results from the National Health and Nutrition Examination Survey  Whitney.
Practice Notes from the AAAAI
Advances in Diagnosing Peanut Allergy
Erythematous Candidiasis
Nonadherence to Asthma Treatment: Getting Unstuck
Omalizumab Effectiveness by Biomarker Status in Patients with Asthma: Evidence From PROSPERO, A Prospective Real-World Study  Thomas B. Casale, MD, Allan.
William J. Calhoun, MD, Tmirah Haselkorn, PhD, Dave P
Thys van der Molen, MD, PhD, Monica Fletcher, MSc, David Price, FRCGP 
Consistently very poorly controlled asthma is associated with greater activity and school impairment in children with severe or difficult-to-treat asthma 
Aimee L. Speck, MD, Michael Hess, MSI, Alan P. Baptist, MD, MPH 
Asthma Exacerbations Associated with Lung Function Decline in Patients with Severe Eosinophilic Asthma  Hector Ortega, MD, ScD, Steven W. Yancey, MS,
Necdet B. Gunsoy, PhD, Sarah M. Cockle, PhD, Steven W
Repeated Episodes of Anaphylaxis with Normal Serum Tryptase but Elevated Levels of Urinary Prostaglandin D2  Phillip Lieberman, MD  The Journal of Allergy.
Penicillin Skin Testing Is a Safe and Effective Tool for Evaluating Penicillin Allergy in the Pediatric Population  Stephanie J. Fox, MD, Miguel A. Park,
Development and Validation of Personalized Prediction to Estimate Future Risk of Severe Exacerbations and Uncontrolled Asthma in Patients with Asthma,
Change in Asthma Control Over Time: Predictors and Outcomes
Phillip Lieberman, MD, Michael Tankersley, MD 
High eosinophil count: A potential biomarker for assessing successful omalizumab treatment effects  William Busse, MD, Sheldon Spector, MD, Karin Rosén,
Effects of Mometasone, Fluticasone, and Montelukast on Bone Mineral Density in Adults with Asthma  Jorge Maspero, MD, Vibeke Backer, DMSci, MD, Ruji Yao,
Thomas B. Casale, MD, Tmirah Haselkorn, PhD, Christina E
News & Notes Journal of Allergy and Clinical Immunology
The Management of Eosinophilic Esophagitis
Phillip Lieberman, MD, David Golden, MD 
Key findings and clinical implications from The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study  Bradley E.
Russell S. Traister, MD, PhD, Merritt L
Melkersson-Rosenthal Syndrome
Anaphylactic Reaction to White-Faced Hornet Sting and Elevated Baseline (Asymptomatic) Serum Tryptase  Phillip Lieberman, MD, Lawrence B. Schwartz, MD,
Justin R. Chen, MD, Brett L. Buchmiller, MD, David A. Khan, MD 
Nicola A. Hanania, MB BS, MS, Bradley E. Chipps, MD, Noelle M
Mapping the Asthma Care Process: Implications for Research and Practice  Alexandra Lelia Dima, PhD, Marijn de Bruin, PhD, Eric Van Ganse, MD, PhD, FRCP 
Real-world attitudes among allergists/immunologists regarding oral immunotherapy and preferred terminology  Bradley E. Chipps, MD, Christina E. Ciaccio,
Sharon Seth, MD, David A. Khan, MD 
Cephalosporin Side Chain Cross-reactivity
Asthma Exacerbations Associated with Lung Function Decline in Patients with Severe Eosinophilic Asthma  Hector Ortega, MD, ScD, Steven W. Yancey, MS,
Granulomatous-lymphocytic Interstitial Lung Disease in a Patient with Common Variable Immunodeficiency  Phil Lieberman, MD, John Routes, MD  The Journal.
Sophie F. Demarche, MPharm, Florence N. Schleich, MD, PhD, Virginie A
Administration of Intravenous Immunoglobulin to a Patient with Hypogammaglobulinemia and Anti-IgA Antibodies  Phillip Lieberman, MD, Rima Rachid, MD 
News & Notes Journal of Allergy and Clinical Immunology
Consistently very poorly controlled asthma, as defined by the impairment domain of the Expert Panel Report 3 guidelines, increases risk for future severe.
Reply The Journal of Allergy and Clinical Immunology: In Practice
Von Ta, MD, Andrew A. White, MD 
Clinical Management of Atopic Dermatitis: Practical Highlights and Updates from the Atopic Dermatitis Practice Parameter 2012  Peter A. Lio, MD, Margaret.
Budesonide Inhalation Suspension Versus Montelukast in Children Aged 2 to 4 Years with Mild Persistent Asthma  Stanley J. Szefler, MD, Lars-Goran Carlsson,
Pedro Giavina-Bianchi, MD, PhD, Shih-Wen Huang, MD 
News & Notes Journal of Allergy and Clinical Immunology
Presentation transcript:

Asthma Exacerbations and Triggers in Children in TENOR: Impact on Quality of Life  Bradley E. Chipps, MD, Tmirah Haselkorn, PhD, Karin Rosén, MD, PhD, David R. Mink, MS, Benjamin L. Trzaskoma, MS, Allan T. Luskin, MD  The Journal of Allergy and Clinical Immunology: In Practice  Volume 6, Issue 1, Pages 169-176.e2 (January 2018) DOI: 10.1016/j.jaip.2017.05.027 Copyright © 2017 The Authors Terms and Conditions

Figure 1 Patient disposition. *Number excludes 3 children who were aged 5 years at baseline. The Journal of Allergy and Clinical Immunology: In Practice 2018 6, 169-176.e2DOI: (10.1016/j.jaip.2017.05.027) Copyright © 2017 The Authors Terms and Conditions

Figure 2 Relationship of PAQLQ score at month 12 and (A) severity and (B) number of asthma exacerbations within the first year of follow-up. The Journal of Allergy and Clinical Immunology: In Practice 2018 6, 169-176.e2DOI: (10.1016/j.jaip.2017.05.027) Copyright © 2017 The Authors Terms and Conditions

Figure 3 Relationship of PAQLQ score at month 12 and number of triggers at baseline. The Journal of Allergy and Clinical Immunology: In Practice 2018 6, 169-176.e2DOI: (10.1016/j.jaip.2017.05.027) Copyright © 2017 The Authors Terms and Conditions

Figure 4 Relationship of the number of asthma triggers at baseline with (A) severity and (B) number of asthma exacerbations. P = .053 for overall difference in the number of asthma triggers by severity of exacerbation category. P < .001 for overall difference in the number of asthma triggers by number of exacerbation category. The Journal of Allergy and Clinical Immunology: In Practice 2018 6, 169-176.e2DOI: (10.1016/j.jaip.2017.05.027) Copyright © 2017 The Authors Terms and Conditions